KOSDAQ - Delayed Quote KRW

Cell Bio Human Tech Co.,Ltd (318160.KQ)

5,930.00
-70.00
(-1.17%)
At close: May 23 at 3:30:30 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
30,750,647.61
28,418,645.60
27,324,211
27,544,537.88
35,160,758.08
Cost of Revenue
19,858,570.15
19,373,705.48
19,595,634.14
19,901,943.54
24,935,297.72
Gross Profit
10,892,077.46
9,044,940.12
7,728,576.86
7,642,594.34
10,225,460.36
Operating Expense
--
5,008,183.34
4,579,181.06
4,107,696.31
4,612,765.24
Operating Income
6,831,004.50
4,036,756.78
3,149,395.80
3,534,898.03
5,612,695.12
Net Non Operating Interest Income Expense
117,680.06
107,989.26
-148,042.32
-351,470.27
-497,372.24
Pretax Income
5,667,693.89
5,190,887.36
-811,822.49
3,540,829.91
4,479,224.79
Tax Provision
557,762.37
812,156.12
1,045,273.68
650,944.44
1,366,700.94
Net Income Common Stockholders
5,109,660.52
4,378,731.24
-1,857,096.17
2,889,885.47
3,131,370.95
Basic EPS
583.50
--
-220.00
413.00
403.00
Diluted EPS
583.50
--
-220.00
413.00
396.00
Basic Average Shares
8,480.38
--
8,441.35
6,997.30
7,770.15
Diluted Average Shares
8,480.38
--
8,441.35
6,997.30
7,907.50
Total Operating Income as Reported
4,811,118.51
4,036,756.74
3,149,395.75
3,534,897.99
5,601,796.25
Rent Expense Supplemental
--
--
--
--
10,558.37
Total Expenses
23,919,643.11
24,381,888.82
24,174,815.20
24,009,639.85
29,548,062.96
Net Income from Continuing & Discontinued Operation
5,109,660.52
4,378,731.24
-1,857,096.17
2,889,885.47
3,131,370.95
Normalized Income
5,097,626.97
4,366,465.11
-1,415,679.66
2,905,532.56
4,455,040.36
Interest Income
--
519,195.97
340,985.81
103,287.96
114,526.96
Interest Expense
--
411,206.70
489,028.13
454,758.22
611,899.21
Net Interest Income
117,680.06
107,989.26
-148,042.32
-351,470.27
-497,372.24
EBIT
7,987,334.18
5,602,094.06
-322,794.36
3,995,588.13
5,091,124
EBITDA
7,987,334.18
7,508,271.72
1,480,654.27
5,856,569.43
6,630,500.14
Reconciled Cost of Revenue
19,858,570.15
19,373,705.48
19,595,634.14
19,901,943.54
24,935,297.72
Reconciled Depreciation
--
1,906,177.66
1,803,448.63
1,860,981.30
1,539,376.14
Net Income from Continuing Operation Net Minority Interest
5,109,660.52
4,378,731.24
-1,857,096.17
2,889,885.47
3,131,370.95
Total Unusual Items Excluding Goodwill
13,347.04
14,541.22
-580,811.20
-19,171.58
-1,904,889.13
Total Unusual Items
13,347.04
14,541.22
-580,811.20
-19,171.58
-1,904,889.13
Normalized EBITDA
7,973,987.14
7,493,730.50
2,061,465.47
5,875,741.01
8,535,389.27
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,313.49
2,275.09
-139,394.69
-3,524.49
-581,219.72
12/31/2021 - 4/20/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

025620.KS Jayjun Cosmetic Co., Ltd.
7,960.00
-10.46%
 
200130.KQ KOLMAR BNH Co.,Ltd.
14,000.00
-0.28%
 
064090.KQ InkredibleBuzz Inc.
2,480.00
-6.59%
 
KAMART.BK Karmarts Public Company Limited
7.75
+0.65%
 
COLPAL.NS Colgate-Palmolive (India) Limited
2,479.40
-0.31%
 
6523.TWO Dr. Wu Skincare Co., Ltd.
139.50
+0.36%